The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation

被引:103
作者
Zilfou, JT
Hoffman, WH
Sank, M
George, DL
Murphy, M
机构
[1] Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA
[2] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.21.12.3974-3985.2001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
While the transactivation function of the tumor suppressor p53 is well understood, less is known about the transrepression functions of this protein. We have previously shown that p53 interacts with the corepressor protein mSin3a (hereafter designated Sin3) in vivo and that this interaction is critical for the ability of p53 to repress gene expression. In the present study, we demonstrate that expression of Sin3 results in posttranslational stabilization of both exogenous and endogenous p53, due to an inhibition of proteasome-mediated degradation of this protein. Stabilization of p53 by Sin3 requires the Sin3-binding domain, determined here to map to the proline-rich region of p53, from amino acids 61 to 75. The correlation between Sin3 binding and stabilization supports the hypothesis that this domain of p53 may normally be subject to a destabilizing influence. The finding that a synthetic mutant of p53 lacking the Sin3-binding domain has an increased half-life in cells, compared to wild-type p53, supports this premise. Interestingly, unlike retinoblastoma tumor suppressor protein, MDMX, and p14(ARF), Sin3 stabilizes p53 in an MDM2-independent manner. The ability of Sin3 to stabilize p53 is consistent with the model whereby these two proteins must exist on a promoter for extended periods, in order for repression to be an effective mechanism of gene regulation. This model is consistent with our data indicating that, unlike the p300-p53 complex, the p53-Sin3 complex is immunologically detectable for prolonged periods following exposure of cells to agents of DNA damage.
引用
收藏
页码:3974 / 3985
页数:12
相关论文
共 53 条
[1]   Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction [J].
Ahn, J ;
Murphy, M ;
Kratowicz, S ;
Wang, A ;
Levine, AJ ;
George, DL .
ONCOGENE, 1999, 18 (43) :5954-5958
[2]  
Alarcón R, 1999, CANCER RES, V59, P6046
[3]   Histone deacetylases: transcriptional repression with SINers and NuRDs [J].
Ayer, DE .
TRENDS IN CELL BIOLOGY, 1999, 9 (05) :193-198
[4]  
BARTEK J, 1990, ONCOGENE, V5, P893
[5]   Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells [J].
BeerRomero, P ;
Glass, S ;
Rolfe, M .
ONCOGENE, 1997, 14 (05) :595-602
[6]   Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo [J].
Bottger, A ;
Bottger, V ;
Sparks, A ;
Liu, WL ;
Howard, SF ;
Lane, DP .
CURRENT BIOLOGY, 1997, 7 (11) :860-869
[7]   Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage [J].
Chehab, NH ;
Malikzay, A ;
Stavridi, ES ;
Halazonetis, TD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13777-13782
[8]   Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage [J].
Chen, LH ;
Agrawal, S ;
Zhou, WQ ;
Zhang, RW ;
Chen, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :195-200
[9]   p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells [J].
Chen, XB ;
Ko, LJ ;
Jayaraman, L ;
Prives, C .
GENES & DEVELOPMENT, 1996, 10 (19) :2438-2451
[10]   ACCUMULATION OF P53 IN A MUTANT-CELL LINE DEFECTIVE IN THE UBIQUITIN PATHWAY [J].
CHOWDARY, DR ;
DERMODY, JJ ;
JHA, KK ;
OZER, HL .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) :1997-2003